This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wieser, R
Right arrow Articles by Massagué, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wieser, R
Right arrow Articles by Massagué, J

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 December; 13(12): 7239-7247

Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.

R Wieser, L Attisano, J L Wrana and J Massagué

Cell Biology and Genetics Program, Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

ABSTRACT

The transforming growth factor beta (TGF-beta) type II receptor (T beta R-II) is a transmembrane serine/threonine kinase that contains two inserts in the kinase region and a serine/threonine-rich C-terminal extension. T beta R-II is required for TGF-beta binding to the type I receptor, with which it forms a heteromeric receptor complex, and its kinase activity is required for signaling by this complex. We investigated the role of various cytoplasmic regions in T beta R-II by altering or deleting these regions and determining the signaling activity of the resulting products in cell lines made resistant to TGF-beta by inactivation of the endogenous T beta R-II. TGF-beta binding to receptor I and responsiveness to TGF-beta in these cells can be restored by transfection of wild-type T beta R-II. Using this system, we show that the kinase insert 1 and the C-terminal tail of T beta R-II, in contrast to the corresponding regions in most tyrosine kinase receptors, are not essential to specify ligand-induced responses. Insert 2 is necessary to support the catalytic activity of the receptor kinase, and its deletion yields a receptor that is unable to mediate any of the responses tested. However, substitution of this insert with insert 2 from the activin receptor, ActR-IIB, does not diminish the ability of T beta R-II to elicit these responses. A truncated T beta R-II lacking the cytoplasmic domain still binds TGF-beta, supports ligand binding to receptor I, and forms a complex with this receptor. However, TGF-beta binding to receptor I facilitated by this truncated T beta R-II fails to inhibit cell proliferation, activate extracellular matrix protein production, or activate transcription from a promoter containing TGF-beta-responsive elements. We conclude that the transcriptional and antiproliferative responses to TGF-beta require both components of a heteromeric receptor complex that differs from tyrosine kinase receptors in its mode of signaling.

Mol Cell Biol. 1993 December; 13(12): 7239-7247




This article has been cited by other articles:

  • Boudreau, H. E., Emerson, S. U., Korzeniowska, A., Jendrysik, M. A., Leto, T. L. (2009). Hepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor {beta}-Dependent Manner: a New Contributor to HCV-Induced Oxidative Stress. J. Virol. 83: 12934-12946 [Abstract] [Full Text]  
  • Belville, C., Marechal, J.-D., Pennetier, S., Carmillo, P., Masgrau, L., Messika-Zeitoun, L., Galey, J., Machado, G., Treton, D., Gonzales, J., Picard, J.-Y., Josso, N., Cate, R. L., di Clemente, N. (2009). Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport. Hum Mol Genet 18: 3002-3013 [Abstract] [Full Text]  
  • Ehata, S., Hanyu, A., Hayashi, M., Aburatani, H., Kato, Y., Fujime, M., Saitoh, M., Miyazawa, K., Imamura, T., Miyazono, K. (2007). Transforming Growth Factor-{beta} Promotes Survival of Mammary Carcinoma Cells through Induction of Antiapoptotic Transcription Factor DEC1. Cancer Res. 67: 9694-9703 [Abstract] [Full Text]  
  • Chen, G., Ghosh, P., Osawa, H., Sasaki, C. Y., Rezanka, L., Yang, J., O'Farrell, T. J., Longo, D. L. (2007). Resistance to TGF-{beta}1 correlates with aberrant expression of TGF-{beta} receptor II in human B-cell lymphoma cell lines. Blood 109: 5301-5307 [Abstract] [Full Text]  
  • Clines, G A, Guise, T A (2005). Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer 12: 549-583 [Abstract] [Full Text]  
  • Koli, K., Wempe, F., Sterner-Kock, A., Kantola, A., Komor, M., Hofmann, W.-K., von Melchner, H., Keski-Oja, J. (2004). Disruption of LTBP-4 function reduces TGF-{beta} activation and enhances BMP-4 signaling in the lung. JCB 167: 123-133 [Abstract] [Full Text]  
  • Dhandapani, K. M., Hadman, M., De Sevilla, L., Wade, M. F., Mahesh, V. B., Brann, D. W. (2003). Astrocyte Protection of Neurons: ROLE OF TRANSFORMING GROWTH FACTOR-{beta} SIGNALING VIA A c-Jun-AP-1 PROTECTIVE PATHWAY. J. Biol. Chem. 278: 43329-43339 [Abstract] [Full Text]  
  • Foletta, V. C., Lim, M. A., Soosairajah, J., Kelly, A. P., Stanley, E. G., Shannon, M., He, W., Das, S., Massague, J., Bernard, O. (2003). Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. JCB 162: 1089-1098 [Abstract] [Full Text]  
  • Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., Massague, J. (2003). Transforming growth factor {beta} signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 100: 8430-8435 [Abstract] [Full Text]  
  • Tang, Q., Staub, C. M., Gao, G., Jin, Q., Wang, Z., Ding, W., Aurigemma, R. E., Mulder, K. M. (2002). A Novel Transforming Growth Factor-beta Receptor-interacting Protein That Is Also a Light Chain of the Motor Protein Dynein. Mol. Biol. Cell 13: 4484-4496 [Abstract] [Full Text]  
  • Singh, K., Batuman, O. A., Akman, H. O., Kedees, M. H., Vakil, V., Hussain, M. M. (2002). Differential, Tissue-specific, Transcriptional Regulation of Apolipoprotein B Secretion by Transforming Growth Factor beta. J. Biol. Chem. 277: 39515-39524 [Abstract] [Full Text]  
  • Danila, D. C., Zhang, X., Zhou, Y., Haidar, J. N. S., Klibanski, A. (2002). Overexpression of Wild-Type Activin Receptor Alk4-1 Restores Activin Antiproliferative Effects in Human Pituitary Tumor Cells. J. Clin. Endocrinol. Metab. 87: 4741-4746 [Abstract] [Full Text]  
  • Chen, W.-B., Lenschow, W., Tiede, K., Fischer, J. W., Kalthoff, H., Ungefroren, H. (2002). Smad4/DPC4-dependent Regulation of Biglycan Gene Expression by Transforming Growth Factor-beta in Pancreatic Tumor Cells. J. Biol. Chem. 277: 36118-36128 [Abstract] [Full Text]  
  • Kakonen, S.-M., Selander, K. S., Chirgwin, J. M., Yin, J. J., Burns, S., Rankin, W. A., Grubbs, B. G., Dallas, M., Cui, Y., Guise, T. A. (2002). Transforming Growth Factor-beta Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways. J. Biol. Chem. 277: 24571-24578 [Abstract] [Full Text]  
  • Bollard, C. M., Rossig, C., Calonge, M. J., Huls, M. H., Wagner, H.-J., Massague, J., Brenner, M. K., Heslop, H. E., Rooney, C. M. (2002). Adapting a transforming growth factor beta -related tumor protection strategy to enhance antitumor immunity. Blood 99: 3179-3187 [Abstract] [Full Text]  
  • Akman, H. O., Zhang, H., Siddiqui, M. A. Q., Solomon, W., Smith, E. L. P., Batuman, O. A. (2001). Response to hypoxia involves transforming growth factor-beta 2 and Smad proteins in human endothelial cells. Blood 98: 3324-3331 [Abstract] [Full Text]  
  • Kim, K.-Y., Jeong, S.-Y., Won, J., Ryu, P.-D., Nam, M.-J. (2001). Induction of Angiogenesis by Expression of Soluble Type II Transforming Growth Factor-beta Receptor in Mouse Hepatoma. J. Biol. Chem. 276: 38781-38786 [Abstract] [Full Text]  
  • Messika-Zeitoun, L., Gouedard, L., Belville, C., Dutertre, M., Lins, L., Imbeaud, S., Hughes, I. A., Picard, J.-Y., Josso, N., di Clemente, N. (2001). Autosomal Recessive Segregation of a Truncating Mutation of Anti-Mullerian Type II Receptor in a Family Affected by the Persistent Mullerian Duct Syndrome Contrasts with Its Dominant Negative Activity in Vitro. J. Clin. Endocrinol. Metab. 86: 4390-4397 [Abstract] [Full Text]  
  • Mori, M., Kida, H., Morishita, H., Goya, S., Matsuoka, H., Arai, T., Osaki, T., Tachibana, I., Yamamoto, S., Sakatani, M., Ito, M., Ogura, T., Hayashi, S. (2001). Microsatellite Instability in Transforming Growth Factor-{beta}1 Type II Receptor Gene in Alveolar Lining Epithelial Cells of Idiopathic Pulmonary Fibrosis. Am. J. Respir. Cell Mol. Bio. 24: 398-404 [Abstract] [Full Text]  
  • Mori, N., Morishita, M., Tsukazaki, T., Giam, C.-Z., Kumatori, A., Tanaka, Y., Yamamoto, N. (2001). Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor {beta} signaling through interaction with CREB-binding protein/p300. Blood 97: 2137-2144 [Abstract] [Full Text]  
  • Chin, B. Y., Mohsenin, A., Li, S. X., Choi, A. M. K., Choi, M. E. (2001). Stimulation of pro-{alpha}1(I) collagen by TGF-{beta}1 in mesangial cells: role of the p38 MAPK pathway. Am. J. Physiol. Renal Physiol. 280: F495-F504 [Abstract] [Full Text]  
  • Quinn, Z. A., Yang, C.-C., Wrana, J. L., McDermott, J. C. (2001). Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res 29: 732-742 [Abstract] [Full Text]  
  • Tobin, S. W., Brown, M. K., Douville, K., Payne, D. C., Eastman, A., Arrick, B. A. (2001). Inhibition of Transforming Growth Factor {beta} Signaling in MCF-7 Cells Results in Resistance to Tumor Necrosis Factor {{alpha}}: A Role for Bcl-2. Cell Growth Differ. 12: 109-117 [Abstract] [Full Text]  
  • Ehrlich, M, Shmuely, A, Henis, Y. (2001). A single internalization signal from the di-leucine family is critical for constitutive endocytosis of the type II TGF-(&bgr;) receptor. J. Cell Sci. 114: 1777-1786 [Abstract]  
  • Zhou, Y., Sun, H., Danila, D. C., Johnson, S. R., Sigai, D. P., Zhang, X., Klibanski, A. (2000). Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling. Mol. Endocrinol. 14: 2066-2075 [Abstract] [Full Text]  
  • Zhao, Y., Young, S. L., McIntosh, J. C., Steele, M. P., Silbajoris, R. (2000). Ontogeny and localization of TGF-beta type I receptor expression during lung development. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L1231-L1239 [Abstract] [Full Text]  
  • Chen, W., Woodruff, T. K., Mayo, K. E. (2000). Activin A-Induced HepG2 Liver Cell Apoptosis: Involvement of Activin Receptors and Smad Proteins. Endocrinology 141: 1263-1272 [Abstract] [Full Text]  
  • Go, C., Li, P., Wang, X.-J. (1999). Blocking Transforming Growth Factor {beta} Signaling in Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated with Increased Angiogenesis. Cancer Res. 59: 2861-2868 [Abstract] [Full Text]  
  • D’Abronzo, F. H., Swearingen, B., Klibanski, A., Alexander, J. M. (1999). Mutational Analysis of Activin/Transforming Growth Factor-{beta} Type I and Type II Receptor Kinases in Human Pituitary Tumors. J. Clin. Endocrinol. Metab. 84: 1716-1721 [Abstract] [Full Text]  
  • Chin, B. Y., Petrache, I., Choi, A. M. K., Choi, M. E. (1999). Transforming Growth Factor beta 1 Rescues Serum Deprivation-induced Apoptosis via the Mitogen-activated Protein Kinase (MAPK) Pathway in Macrophages. J. Biol. Chem. 274: 11362-11368 [Abstract] [Full Text]  
  • Donaldson, C. J., Vaughan, J. M., Corrigan, A. Z., Fischer, W. H., Vale, W. W. (1999). Activin and Inhibin Binding to the Soluble Extracellular Domain of Activin Receptor II. Endocrinology 140: 1760-1766 [Abstract] [Full Text]  
  • Guo, Y., Kyprianou, N. (1999). Restoration of Transforming Growth Factor {beta} Signaling Pathway in Human Prostate Cancer Cells Suppresses Tumorigenicity via Induction of Caspase-1-mediated Apoptosis. Cancer Res. 59: 1366-1371 [Abstract] [Full Text]  
  • Muro-Cacho, C. A., Munoz-Antonia, T., Livingston, S., Klotch, D. (1999). Transforming Growth Factor {beta} Receptors and p27kip in Thyroid Carcinoma. Arch Otolaryngol Head Neck Surg 125: 76-81 [Abstract] [Full Text]  
  • Kurokawa, M., Mitani, K., Imai, Y., Ogawa, S., Yazaki, Y., Hirai, H. (1998). The t(3;21) Fusion Product, AML1/Evi-1, Interacts With Smad3 and Blocks Transforming Growth Factor-beta -Mediated Growth Inhibition of Myeloid Cells. Blood 92: 4003-4012 [Abstract] [Full Text]  
  • Choy, L., Derynck, R. (1998). The Type II Transforming Growth Factor (TGF)-beta Receptor-interacting Protein TRIP-1 Acts as a Modulator of the TGF-beta Response. J. Biol. Chem. 273: 31455-31462 [Abstract] [Full Text]  
  • Guise, T. A., Mundy, G. R. (1998). Cancer and Bone. Endocr. Rev. 19: 18-54 [Abstract] [Full Text]  
  • Lawler, S., Feng, X.-H., Chen, R.-H., Maruoka, E. M., Turck, C. W., Griswold-Prenner, I., Derynck, R. (1997). The Type II Transforming Growth Factor-beta Receptor Autophosphorylates Not Only on Serine and Threonine but Also on Tyrosine Residues. J. Biol. Chem. 272: 14850-14859 [Abstract] [Full Text]  
  • Wang, X.-J., Greenhalgh, D. A., Bickenbach, J. R., Jiang, A., Bundman, D. S., Krieg, T., Derynck, R., Roop, D. R. (1997). Expression of a dominant-negative type II transforming growth factor beta  (TGF-beta ) receptor in the epidermis of transgenic mice blocks TGF-beta -mediated growth inhibition. Proc. Natl. Acad. Sci. USA 94: 2386-2391 [Abstract] [Full Text]  
  • White, D. W., Kuropatwinski, K. K., Devos, R., Baumann, H., Tartaglia, L. A. (1997). Leptin Receptor (OB-R) Signaling. CYTOPLASMIC DOMAIN MUTATIONAL ANALYSIS AND EVIDENCE FOR RECEPTOR HOMO-OLIGOMERIZATION. J. Biol. Chem. 272: 4065-4071 [Abstract] [Full Text]  
  • Chen, Y., Lebrun, J.-J., Vale, W. (1996). Regulation of transforming growth factor beta - and activin-induced transcription by mammalian Mad proteins. Proc. Natl. Acad. Sci. USA 93: 12992-12997 [Abstract] [Full Text]  
  • Charng, M.-J., Kinnunen, P., Hawker, J., Brand, T., Schneider, M. D. (1996). FKBP-12 Recognition Is Dispensable For Signal Generation by Type I Transforming Growth Factor-beta Receptors. J. Biol. Chem. 271: 22941-22944 [Abstract] [Full Text]  
  • Anders, R. A., Leof, E. B. (1996). Chimeric Granulocyte/Macrophage Colony-stimulating Factor/Transforming Growth Factor-beta (TGF-beta ) Receptors Define a Model System for Investigating the Role of Homomeric and Heteromeric Receptors in TGF-beta Signaling. J. Biol. Chem. 271: 21758-21766 [Abstract] [Full Text]  
  • Wang, J., Han, W., Zborowska, E., Liang, J., Wang, X., Willson, J. K.V., Sun, L., Brattain, M. G. (1996). Reduced Expression of Transforming Growth Factor beta Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells. J. Biol. Chem. 271: 17366-17371 [Abstract] [Full Text]  
  • Yamamoto, H., Ueno, H., Ooshima, A., Takeshita, A. (1996). Adenovirus-mediated Transfer of a Truncated Transforming Growth Factor-beta (TGF-beta ) Type II Receptor Completely and Specifically Abolishes Diverse Signaling by TGF-beta in Vascular Wall Cells in Primary Culture. J. Biol. Chem. 271: 16253-16259 [Abstract] [Full Text]  
  • Saitoh, M., Nishitoh, H., Amagasa, T., Miyazono, K., Takagi, M., Ichijo, H. (1996). Identification of Important Regions in the Cytoplasmic Juxtamembrane Domain of Type I Receptor That Separate Signaling Pathways of Transforming Growth Factor-beta. J. Biol. Chem. 271: 2769-2775 [Abstract] [Full Text]  
  • Feng, X.-H., Filvaroff, E. H., Derynck, R. (1995). Transforming Growth Factor-beta (TGF-beta)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-beta Receptor Complex. J. Biol. Chem. 270: 24237-24245 [Abstract] [Full Text]  
  • Choi, M. E., Ballermann, B. J. (1995). Inhibition of Capillary Morphogenesis and Associated Apoptosis by Dominant Negative Mutant Transforming Growth Factor-beta Receptors. J. Biol. Chem. 270: 21144-21150 [Abstract] [Full Text]  
  • Rodriguez, C., Chen, F., Weinberg, R. A., Lodish, H. F. (1995). Cooperative Binding of Transforming Growth Factor (TGF)-[IMAGE]2 to the Types I and II TGF-[IMAGE] Receptors. J. Biol. Chem. 270: 15919-15922 [Abstract] [Full Text]  
  • Chen, R.-H., Moses, H. L., Maruoka, E. M., Derynck, R., Kawabata, M. (1995). Phosphorylation-dependent Interaction of the Cytoplasmic Domains of the Type I and Type II Transforming Growth Factor-[IMAGE] Receptors. J. Biol. Chem. 270: 12235-12241 [Abstract] [Full Text]  
  • Brand, T., Schneider, M. D. (1995). Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription. J. Biol. Chem. 270: 8274-8284 [Abstract] [Full Text]  
  • Hartsough, M. T., Mulder, K. M. (1995). Transforming Growth Factor beta Activation of p44[IMAGE] in Proliferating Cultures of Epithelial Cells. J. Biol. Chem. 270: 7117-7124 [Abstract] [Full Text]  
  • Vivien, D., Attisano, L., Massagué, J. (1995). Signaling Activity of Homologous and Heterologous Transforming Growth Factor-beta Receptor Kinase Complexes. J. Biol. Chem. 270: 7134-7141 [Abstract] [Full Text]  
  • Moustakas, A., Takumi, T., Lin, H. Y., Lodish, H. F. (1995). GH3 Pituitary Tumor Cells Contain Heteromeric Type I and Type II Receptor Complexes for Transforming Growth Factor beta and Activin-A. J. Biol. Chem. 270: 765-769 [Abstract] [Full Text]  
  • Xie, T, Finelli, A., Padgett, R. (1994). The Drosophila saxophone gene: a serine-threonine kinase receptor of the TGF-beta superfamily. Science 263: 1756-1759 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»